3 ms·
Intel drank the management consultant kool-aid like many large pharmaceuticals corps, relying more on financial engineering than their research pipeline to comp
by starfallg 5y ago
Intel drank the management consultant kool-aid like many large pharmaceuticals corps, relying more on financial engineering than their research pipeline to compete. The flip side is that they have lots of money to splash around. Companies like Pfizer for example.
- christophilus 5y agoDid they? I thought they made a heavy bet that hasn’t paid off (and maybe never will).
- cisvolk1016 5y agoSo if Intel drops $0.8B on a risktaker learning from what I. B. M. did to make Watson and not make those mistakes. What new thing could come from that? A new category product is what Intel should look for around the corner(s).
- starfallg 5y agoYou're right for the 10nm (7nm) process development. They focused on shrinking the wrong parts and ended up with an inferior product. Instead of changing direction, they doubled down.
- galangalalgol 5y agoWas this a case of a leader refusing to be wrong, or engineers thinking "we almost have this, give us another shot."
- GuuD 5y agoI have no idea, but isn’t it the usual real-world case of “it’s complicated, and it’s both”?